EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Visualizing the Invisible: Dual Click Imaging of Ruthenium-Based Photoactivated Chemotherapy Agents and Their DNA Synthesis Inhibition in Fixed Cancer Cells

Anja Busemann, Lisa Rieger, Rachael M Cunningham, Sam C Davidse, Irene Regeni iD, Ingrid Flaspohler, Claudia Schmidt iD, Xue-Quan Zhou, Vincent van Rixel, Maxime A Siegler iD, Ingo Ott iD, Sylvia E Le Dévédec iD und 3 weitere

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.5c13249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Anja Busemann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, Netherlands. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, DNA, Coordination Complexes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, Karlsruhe Institute of Technology, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Like many drugs, ruthenium-based photoactivated chemotherapy (PACT) complexes are hard to follow in cells due to their absence of emissive properties. Here, two alkyne-functionalized Ru-based PACT compounds with the formula [Ru(HCC-tpy)(N̂N)(Hmte)](PF 6 ) 2 were synthesized, where HCC-tpy = 4′-ethynyl-2,2′:6′,2″-terpyridine, N̂N = 3,3′-biisoquinoline (i-biq, [ 2 ](PF 6 ) 2 ) or di(isoquinolin-3-yl)amine (i-Hdiqa, [ 4 ](PF 6 ) 2 ), and Hmte = 2-(methylthio)ethanol. Their challenging synthesis involved a protection–deprotection strategy to avoid the reaction of the free alkyne group with the coordinatively unsaturated ruthenium center. The thermal stability and photosubstitution quantum yield (Φ [ 2 ] = 0.022 and Φ [ 4 ] = 0.080) of the PACT complexes were essentially preserved upon alkyne functionalization. Interestingly, however, cellular uptake was doubled after alkyne functionalization, resulting in increased cytotoxicity against A549 cancer cells for both complexes in the dark and after green light activation (EC 50,light = 5 and 7 μM, respectively). To follow the complexes and see the effect of light activation, post-treatment fluorophore labeling via copper-catalyzed azide–alkyne cycloaddition was realized in fixed cells at 2 different time points, which allowed for imaging the otherwise invisible molecules. The images showed that the Ru complexes accumulated in the cytoplasm only after light irradiation and that they colocalized with the lysosomes and the Golgi apparatus. Moreover, we combined this approach with metabolic labeling of DNA, and showed by dual click imaging that DNA replication was inhibited by complex 4 . The strategy described herein, pioneered for nonemissive, photosubstitutionally active ruthenium complexes, opens a new avenue for investigating the selective attack of lung cancer cells by PACT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumAntineoplastic AgentsDNACoordination ComplexesHumansClick ChemistryCell Line, TumorMolecular Structure

Substanzen

RutheniumAntineoplastic AgentsDNACoordination Complexes

Autor:innen und Institutionen

  • Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, Netherlands.
  • Institute of Organic Chemistry, Karlsruhe Institute of Technology (KIT), Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany.
  • Department of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403, United States.
  • Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333 CC Leiden, Netherlands.
  • Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstrasse 55, 38106 Braunschweig, Germany.
  • Small Molecule X-Ray Facility, Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States.

ORCID-Profile: Irene Regeni, Claudia Schmidt, Maxime A Siegler, Ingo Ott, Sylvia E Le Dévédec, Hans-Achim Wagenknecht, Victoria J DeRose, Sylvestre Bonnet

Förderung

  • National Science Foundation
  • Karlsruhe Institute of Technology
  • Deutsche Forschungsgemeinschaft
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Busemann, A., Rieger, L., Cunningham, R. M., Davidse, S. C., Regeni, I., Flaspohler, I., Schmidt, C., Zhou, X. Q., van Rixel, V., Siegler, M. A., Ott, I., Le Dévédec, S. E., Wagenknecht, H. A., DeRose, V. J., & Bonnet, S. (2025). Visualizing the Invisible: Dual Click Imaging of Ruthenium-Based Photoactivated Chemotherapy Agents and Their DNA Synthesis Inhibition in Fixed Cancer Cells. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c13249

Vancouver

Busemann A, Rieger L, Cunningham RM, Davidse SC, Regeni I, Flaspohler I, et al. Visualizing the Invisible: Dual Click Imaging of Ruthenium-Based Photoactivated Chemotherapy Agents and Their DNA Synthesis Inhibition in Fixed Cancer Cells. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c13249

BibTeX
@article{Busemann2025,
  author = {Busemann, Anja and Rieger, Lisa and Cunningham, Rachael M and Davidse, Sam C and Regeni, Irene and Flaspohler, Ingrid and Schmidt, Claudia and Zhou, Xue-Quan and van Rixel, Vincent and Siegler, Maxime A and Ott, Ingo and Le Dévédec, Sylvia E and Wagenknecht, Hans-Achim and DeRose, Victoria J and Bonnet, Sylvestre},
  title = {Visualizing the Invisible: Dual Click Imaging of Ruthenium-Based Photoactivated Chemotherapy Agents and Their DNA Synthesis Inhibition in Fixed Cancer Cells},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.5c13249}
}
Kostenlos starten →